Study ID: C38072-AS-30025 | 2015-000865-29
Study Title
- Study of Reslizumab in Participants With Uncontrolled Asthma and Elevated Blood Eosinophils
Teva Identifier
- C38072-AS-30025 | 2015-000865-29
ClinicalTrials.gov Identifier
- NCT02452190
Study Status
- Completed
Trial Condition(s)
- Asthma
Interventions
- Drug: Reslizumab | Drug: Placebo
Study Description
- Please refer to ClinicalTrials.gov for a description of the trial

Key Participation Requirements
Gender
- Female, Male
Age Range
- 12 Years and older
Trial Duration
- September 28, 2015 - January 31, 2018
Phase
- Phase 3
Study Type
Interventional